The recent acquisitions by pharmaceutical giants Johnson & Johnson and Bristol Myers Squibb, worth a combined $28billion, highlight the growing interest in mental health treatment.Read More

You might also be interested in reading Ripple CLO Stuart Alderoty Says ‘Washington Must Finish the Job on Crypto Clarity’.